| 基因名 | 疾病 | 靶向药 | 化疗药 | 基因突变 | 临床解释 |
|---|---|---|---|---|---|
| HYOU1 | 0 | 0 | |||
| HUWE1 | 0 | 0 | |||
| HTR1A | 0 | 0 | |||
| HSPH1 | 结直肠癌,胃腺癌 | 氟尿嘧啶,顺铂,奥沙利铂, | 2 | 3 | |
| HSPD1 | 0 | 0 | |||
| HSPB1 | 胰腺导管腺癌 | 吉西他滨, | 1 | 1 | |
| HSPA8 | 0 | 0 | |||
| HSPA5 | 结直肠癌 | 氟尿嘧啶, | 1 | 1 | |
| HSPA4 | 0 | 0 | |||
| HSPA1B | 0 | 0 | |||
| HSP90AB1 | 0 | 0 | |||
| HSP90AA1 | 0 | 0 | |||
| HSD3B2 | 0 | 0 | |||
| HSD3B1 | 0 | 0 | |||
| HSD17B4 | 0 | 0 | |||
| HSD17B3 | 0 | 0 | |||
| HRH2 | 0 | 0 | |||
| HRAS | 癌症,结直肠癌,滤泡性甲状腺癌,头颈癌,非小细胞肺癌,皮肤鳞状细胞癌,甲状腺癌 | AZD8055,比美替尼、贝美替尼,西妥昔单抗,EGFR Inhibitor,厄洛替尼,依维莫司,PD0325901,司美替尼,维莫非尼, | 10 | 15 | |
| HOXD13 | 0 | 0 | |||
| HOXD11 | 0 | 0 | |||
| HOXC13 | 0 | 0 | |||
| HOXB13 | 前列腺癌 | 1 | 2 | ||
| HOXA9 | 0 | 0 | |||
| HOXA3 | 0 | 0 | |||
| HOXA13 | 0 | 0 | |||
| HOXA11 | 0 | 0 | |||
| HNRNPH1 | 0 | 0 | |||
| HNF4A | 0 | 0 | |||
| HNF1B | 0 | 0 | |||
| HNF1A | 0 | 0 | |||
| HMOX1 | 肾细胞癌 | 索拉非尼,舒尼替尼, | 1 | 1 | |
| HMCN1 | 0 | 0 | |||
| HMBS | 0 | 0 | |||
| HLF | 0 | 0 | |||
| HLA-DRB1 | 0 | 0 | |||
| HLA-DRA | 皮肤黑色素瘤 | 阿特朱单抗，阿替利珠单抗,纳武单抗（纳武利尤单抗）,派姆单抗（帕博利珠单抗）, | 1 | 1 | |
| HLA-C | 结直肠癌 | Adoptive T-cell Transfer, | 1 | 1 | |
| HLA-B | 0 | 0 | |||
| HLA-A | 0 | 0 | |||
| HIST3H3 | 0 | 0 | |||
| HIST2H3D | 0 | 0 | |||
| HIST2H3C | 0 | 0 | |||
| HIST1H4I | 0 | 0 | |||
| HIST1H3J | 0 | 0 | |||
| HIST1H3I | 0 | 0 | |||
| HIST1H3H | 0 | 0 | |||
| HIST1H3G | 0 | 0 | |||
| HIST1H3F | 0 | 0 | |||
| HIST1H3E | 0 | 0 | |||
| HIST1H3D | 0 | 0 | |||
| HIST1H3C | 0 | 0 | |||
| HIST1H3B | 0 | 0 | |||
| HIST1H3A | 0 | 0 | |||
| Hist1h2bo | 0 | 0 | |||
| HIST1H2BD | 0 | 0 | |||
| Hist1h2bc | 0 | 0 | |||
| Hist1h2al | 0 | 0 | |||
| Hist1h2ac | 0 | 0 | |||
| HIST1H1E | 0 | 0 | |||
| HIST1H1D | 0 | 0 | |||
| HIST1H1C | 0 | 0 | |||
| HIP1 | 0 | 0 | |||
| HIF1A | 结直肠癌,胰腺腺癌,肾细胞癌,肉瘤 | 帕唑帕尼,培唑帕尼, | 3 | 4 | |
| HGF | 多形胶质母细胞瘤 | SGX523, | 1 | 1 | |
| HFE | 0 | 0 | |||
| HEY1 | 0 | 0 | |||
| HES1 | 0 | 0 | |||
| HERC2 | 0 | 0 | |||
| HECW1 | 0 | 0 | |||
| HDAC9 | 0 | 0 | |||
| HDAC8 | 0 | 0 | |||
| HDAC7 | 0 | 0 | |||
| HDAC6 | 0 | 0 | |||
| HDAC4 | 0 | 0 | |||
| HDAC3 | 0 | 0 | |||
| HDAC2 | 肾细胞癌 | 艾贝司他,帕唑帕尼,培唑帕尼, | 1 | 1 | |
| HDAC1 | 0 | 0 | |||
| HCN1 | 0 | 0 | |||
| HCLS1 | 0 | 0 | |||
| HCK | 0 | 0 | |||
| HCAR2 | 0 | 0 | |||
| HAVCR2 | 非小细胞肺癌 | PD-1 Inhibitor,TIM-3 Inhibitor, | 1 | 2 | |
| HAUS6 | 0 | 0 | |||
| HAUS2 | 0 | 0 | |||
| HAPLN1 | 0 | 0 | |||
| H3f3c | 0 | 0 | |||
| H3F3B | 软骨母细胞瘤 | 1 | 1 | ||
| H3F3A | 骨巨细胞瘤,弥漫性固有桥脑胶质瘤,多形性胶质母细胞瘤,小儿低级别胶质瘤（PLGG）。 | 3 | 5 | ||
| H3C8 | 0 | 0 | |||
| H3C7 | 0 | 0 | |||
| H3C6 | 0 | 0 | |||
| H3C4 | 0 | 0 | |||
| H3C3 | 0 | 0 | |||
| H3C2 | 0 | 0 | |||
| H3C14 | 0 | 0 | |||
| H3C13 | 0 | 0 | |||
| H3C11 | 0 | 0 | |||
| H3C10 | 0 | 0 | |||
| H3C1 | 0 | 0 | |||
| H3-4 | 0 | 0 | |||
| H3-3B | 0 | 0 | |||
| H3-3A | 0 | 0 | |||
| H2BC5 | 0 | 0 | |||
| H2AX | 0 | 0 | |||
| H1-2 | 0 | 0 |
Copyright © 2020 基因医生
京ICP备13051264号-65 
京公网安备
11010802036025号